{
  "id": "Fuhrman_ccRCC_assessment.v1",
  "gdl_version": "2.0",
  "concept": "gt0001",
  "language": {
    "original_language": "ISO_639-1::en"
  },
  "description": {
    "original_author": {
      "date": "2017-06-25",
      "name": "Syeeda S Farruque",
      "organisation": "Cambio Healthcare Systems",
      "email": "models@cambiocds.com"
    },
    "other_contributors": [
      "Dennis Forslund, Cambio Healthcare Systems"
    ],
    "lifecycle_state": "Author draft",
    "details": {
      "sv": {
        "id": "sv",
        "purpose": "Att vid klarcellig njurcancer värdera prognos uttryckt i femårsöverlevnad baserat på cellkaraktäristika.\r\n",
        "keywords": [
          "Fuhrman Nuclear Grade",
          "klarcellig njurcancer",
          "njurcancer",
          "5-årsöverlevnad",
          "femårsöverlevnad",
          "onkologi"
        ],
        "use": "Använd för att vid klarcellig njurcancer värdera prognos uttryckt i femårsöverlevnad baserat på cellkaraktäristika.\r\n\r\nFyra parametrar bedöms och poängsätts enligt skala: \r\n- Cellkärnans diameter\r\n- Cellkärnans form\r\n- Nukleoler\r\n- Bisarra, ofta multilobulerade cellkärnor \r\n\r\nGradering enligt Fuhrman (delvis citerad från referens 2):\r\n\r\nGrad 1\r\nCellkärnorna i tumörcellerna är små (< 10 µm), hyperkromatiska och runda (likt mogna lymfocyter), utan synliga nukleoler.\r\n\r\nGrad 2\r\nMed x10 förstoring ses större cellkärnor (15 µm) med oregelbunden kontur, samt små nukleoler.\r\n\r\nGrad 3\r\nMed x10 förstoring ses större cellkärnor (20 µm), eventuellt med oval form, med klart oregelbunden kontur. Prominenta nukleoler.\r\n\r\nGrad 4\r\nEgenskaper som vid grad 3 med tillägg av bisarra ofta multilobulerade cellkärnor som\r\ninnehåller stora kromatinaggregat\r\n\r\n5-årsöverlevnad baserat på indelning enligt ovan:\r\nGrad I: 96%\r\nGrad II: 84%\r\nGrad III: 59%\r\nGrad IV: 31%",
        "misuse": "Detta instrument är endast avsett att användas som understöd till klinisk bedömning baserad på grundligt utförd utredning.",
        "copyright": "© Cambio Healthcare Systems"
      },
      "en": {
        "id": "en",
        "purpose": "The Fuhrman Nuclear Grade for Clear Cell Renal Cell Carcinoma (ccRCC) tool uses the physical appearance of cells in renal tissue to provide a prognostic assessment of  tumour cells. This provides a pathological grading system specifically for RCC (of the clear cell type) which can be used to independantly predict cancer-specific survival. Higher grades correlates with a worsening prognosis.",
        "keywords": [
          "Fuhrman Nuclear Grade",
          "Clear Cell Renal Cell Carcinoma",
          "SSIGN",
          "5 year survival"
        ],
        "use": "To be used with patients who have clear cell Renal Cell Carcinomas (RCC) and where pathological assessments needed to visualise the cells are available.\r\n\r\nThere are 4 variables that are scored and which contribute to the 4 grades:\r\n\r\nNuclear diameter, Nuclear shape, Nucleoli and Bizzare often multilobed nuclei and/or spindle cells. \r\n\r\nThe 5 year survival figures for each grade:\r\n\r\nGrade I: 96%\r\nGrade II: 84%\r\nGrade III: 59%\r\nGrade IV: 31%",
        "misuse": "As there are no validated scoring systems for providing ccRCC survival, this tool and other associated tools (such as the SSIGN) should be used with sound clinical judgment to provide a more rounded prognostic picture.",
        "copyright": "© Cambio Healthcare Systems"
      }
    },
    "other_details": {
      "references": "Ref. 1: Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol. 1982 Oct;6(7):655-63.\r\n\r\nRef. 2: Cancercentrum. Njurcancer, Nationell Kvalitetsregisterrapport. 2013. Available from:\r\nhttps://www.cancercentrum.se/globalassets/cancerdiagnoser/urinvagar/njurcancer/kvalitetsregister/njure_kvalregrapp_2014-11-21.pdf"
    }
  },
  "definition": {
    "data_bindings": {
      "gt0002": {
        "id": "gt0002",
        "model_id": "openEHR-EHR-OBSERVATION.fuhrman_nuclear_grade_for_cc_renal_cell_carcinoma.v1",
        "template_id": "openEHR-EHR-OBSERVATION.fuhrman_nuclear_grade_for_cc_renal_cell_carcinoma.v1",
        "type": "INPUT",
        "elements": {
          "gt0005": {
            "id": "gt0005",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0019]"
          }
        }
      },
      "gt0015": {
        "id": "gt0015",
        "model_id": "openEHR-EHR-EVALUATION.fuhrman_nuclear_grade_ccrcc_assessment.v1",
        "template_id": "openEHR-EHR-EVALUATION.fuhrman_nuclear_grade_ccrcc_assessment.v1",
        "type": "OUTPUT",
        "elements": {
          "gt0016": {
            "id": "gt0016",
            "path": "/data[at0001]/items[at0002]"
          }
        }
      }
    },
    "rules": {
      "gt0009": {
        "id": "gt0009",
        "priority": 4,
        "when": [
          "$gt0005|Grade|==1|local::at0022|Grade I|"
        ],
        "then": [
          "$gt0016|5 Year Survival|=1|local::at0003|96%|"
        ]
      },
      "gt0010": {
        "id": "gt0010",
        "priority": 3,
        "when": [
          "$gt0005|Grade|==2|local::at0023|Grade II|"
        ],
        "then": [
          "$gt0016|5 Year Survival|=2|local::at0004|84%|"
        ]
      },
      "gt0011": {
        "id": "gt0011",
        "priority": 2,
        "when": [
          "$gt0005|Grade|==3|local::at0024|Grade III|"
        ],
        "then": [
          "$gt0016|5 Year Survival|=3|local::at0005|59%|"
        ]
      },
      "gt0012": {
        "id": "gt0012",
        "priority": 1,
        "when": [
          "$gt0005|Grade|==4|local::at0025|Grade IV|"
        ],
        "then": [
          "$gt0016|5 Year Survival|=4|local::at0006|31%|"
        ]
      }
    }
  },
  "ontology": {
    "term_definitions": {
      "sv": {
        "id": "sv",
        "terms": {
          "gt0001": {
            "id": "gt0001",
            "text": "Fuhrman Nuclear Grade ccRCC utvärdering",
            "description": "Fuhrman Nuclear Grade for Clear Cell Renal Cell Carcinoma (ccRCC) är ett instrument för bedömning av prognos vid klarcellig njurcellscancer."
          },
          "gt0004": {
            "id": "gt0004",
            "text": "Gradering",
            "description": "Gradering baserat på samtliga faktorer."
          },
          "gt0005": {
            "id": "gt0005",
            "text": "Gradering",
            "description": "Gradering baserat på samtliga faktorer."
          },
          "gt0007": {
            "id": "gt0007",
            "text": "5-årsöverlevnad",
            "description": "Femårsöverlevnad baserat på gradering i enlighet med Fuhrman Nuclear Grade."
          },
          "gt0008": {
            "id": "gt0008",
            "text": "CDS Grad"
          },
          "gt0009": {
            "id": "gt0009",
            "text": "Grad I överlevnad"
          },
          "gt0010": {
            "id": "gt0010",
            "text": "Grad II överlevnad"
          },
          "gt0011": {
            "id": "gt0011",
            "text": "Grad III överlevnad"
          },
          "gt0012": {
            "id": "gt0012",
            "text": "Grad IV överlevnad"
          },
          "gt0014": {
            "id": "gt0014",
            "text": "Gradering",
            "description": "Gradering baserat på samtliga faktorer."
          },
          "gt0016": {
            "id": "gt0016",
            "text": "5-årsöverlevnad",
            "description": "Femårsöverlevnad baserat på gradering i enlighet med Fuhrman Nuclear Grade."
          },
          "gt0017": {
            "id": "gt0017",
            "text": "Gradering"
          }
        }
      },
      "en": {
        "id": "en",
        "terms": {
          "gt0001": {
            "id": "gt0001",
            "text": "Fuhrman_Nuclear_Grade_ccRCC_assessment",
            "description": "The Fuhrman Nuclear Grade for Clear Cell Renal Cell Carcinoma (ccRCC) tool uses the physical appearance of cells in renal tissue to provide a prognostic tool to assess tumour cells. This model helps to allocate the 5 year survival figures to each of the 4 Grades"
          },
          "gt0004": {
            "id": "gt0004",
            "text": "Grade",
            "description": "Grade based on selections of the 4 variables, nuclear diameter, shap, appearance of nucleoli and presence of other bizarre findings"
          },
          "gt0005": {
            "id": "gt0005",
            "text": "Grade",
            "description": "Grade based on selections of the 4 variables, nuclear diameter, shap, appearance of nucleoli and presence of other bizarre findings"
          },
          "gt0007": {
            "id": "gt0007",
            "text": "5 Year Survival",
            "description": "The 5 year survival figures for each grade"
          },
          "gt0008": {
            "id": "gt0008",
            "text": "set grade"
          },
          "gt0009": {
            "id": "gt0009",
            "text": "Grade I survival"
          },
          "gt0010": {
            "id": "gt0010",
            "text": "Grade II survival"
          },
          "gt0011": {
            "id": "gt0011",
            "text": "Grade III survival"
          },
          "gt0012": {
            "id": "gt0012",
            "text": "Grade IV survival"
          },
          "gt0014": {
            "id": "gt0014",
            "text": "Grade",
            "description": "Grade based on selections of the 4 variables, nuclear diameter, shap, appearance of nucleoli and presence of other bizarre findings"
          },
          "gt0016": {
            "id": "gt0016",
            "text": "5 Year Survival",
            "description": "The 5 year survival figures for each grade"
          },
          "gt0017": {
            "id": "gt0017",
            "text": "grade"
          }
        }
      }
    }
  }
}